Clean Biomanufacturing. Zero Clogs. Better Yields.
We’re building the world’s first inertial microfluidic perfusion filter that removes dead cells, reduces impurities, and keeps yield steady for weeks.
-
🧬 +14% yield and 2–4% viability boost for continuous runs without compromise.
-
💊 50% fewer Host Cell Proteins, resulting in cleaner biologics and easier purification.
-
⚙️ Plug-and-play, GMP-ready filter usable from 2L to 2000L — with zero clogging.
💬 “We lose yield in membrane filters — this could be huge.” – MNC R&D Lead. 📈 “Dead cell removal during perfusion? Game-changing.” – Biotech Stakeholder. 🔍 “We’re always looking for clean, scalable alternatives.” – CDMO Director
🔴 The Problem
-
❌ Filters clog mid-run
Membrane-based ATFs/TFFs suffer from fouling, reducing efficiency. -
❌ Residual HCPs remain
Host Cell Proteins compromise monoclonal antibody quality. -
❌ Product yield drops
Long-term runs result in filter-induced product loss. -
❌ Downtime & interruptions
Operators must pause for cleaning or replacement.
🟢 Our Solution
-
✅ Clog-Free Microfluidics
No membranes, no fouling — stable perfusion every time. -
✅ Dead Cell Removal Built-In
Reduces HCPs by up to 50% at the source. -
✅ +14% Higher Yield
Consistent viability and concentration over longer runs. -
✅ Zero Filter Replacements
No downtime. Plug-and-play cartridge runs continuously.
Easy integration into existing bioreactors
Click Here
Saves Upto S$25 K each run and sustains the cell throughput
1
Clog-Free Operation
Engineered with advanced microfluidics, CelltoMix eliminates the risk of clogging — even during prolonged use. This ensures consistent performance and a stable yield over time, reducing downtime and maintenance compared to traditional filters.
2
Ultra-High Cell Density
Achieve up to 100 million cells per milliliter without compromising flow or separation efficiency. Ideal for applications requiring maximum biomass concentration, from cell culture to bioproduction.
3
Enriches Cell Viability — Exclusive Feature
CelltoMix does more than filter — it enhances the health and viability of your cultures. Each cycle through the system improves bioreactor performance by up to 5%, helping you unlock higher yields and better-quality results with no added processing steps.
At CelltoMix, we are redefining bioprocessing through next-generation microfluidic technology. Founded by leading scientists and engineers, our mission is to solve the industry’s toughest filtration challenges — starting with clog-free, high-yield microfilters.
With a science-first approach and over two decades of international research experience behind our core team, we’re building tools that increase cell culture productivity, reduce operational downtime, and optimize bioreactor performance.
We believe innovation in life sciences begins at the microscopic level — and that’s exactly where we thrive.
Dr. Shireen Goh
Co-Founder
Dr. Shireen Goh is scientific co-founder of Celltomix and Associate Professor at SUTD, specializing in microfluidics and biomanufacturing with technologies licensed to industry, including Erbi Biosystems (acquired by Merck in 2022).
Dr. Danny van Noort
Co-Founder
Dr. Danny van Noort is an internationally recognized researcher with 25+ years of experience in physics, microtechnology, and biomedical engineering. He specializes in biosensors, DNA computers, organ-on-chips, and 3D cell models, with numerous publications and global lectures.
Leo Siang Kwong
Co-Founder
Leo Siang Kwong is an expert in digital transformation and automation, with 25+ years of experience in technology and engineering. A certified PMP and ScrumMaster, he specializes in leading large-scale digital initiatives, smart manufacturing, and ERP solutions, translating business vision into scalable innovation.
Pranav Garg
Co-Founder
Pranav Garg is a young co-founder with a strong foundation in marketing and entrepreneurship. As the founder of a successful marketing firm in India, he specializes in strategic marketing and business development, driving growth and innovation in his ventures.